Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million....
Hasten Biopharma entered a $325 million agreement for greater China rights to a PCSK9 inhibitor from LIB Therapeutics. Meanwhile, Insilico Medicine out-licensed global rights to a...
Global market risk off is gathering momentum. China’s currency declined another 1.06% versus the dollar this week to the weakest level since 2007. The Chilean peso dropped 5.0%,...
China has the world’s largest population and second-largest economy, so it’s always wise to keep an eye on the Chinese economy and stock market. Today we look at the latter, eyeing...
Both European and US stocks surged overnight as the USD tumbled against the majors as signs that the US economy maybe slowing faster than expected came through in consumer...
Wall Street finished the trading week on a high note on Friday as Fed Chair Powell’s long awaited speech at the Jackson Hole conference was received with mild aplomb, with currency...
The central banker talkfest at Jackson Hole ramps up tonight and risk markets will completely hinge – or unhinge – on what Fed Chair Powell has to say with Wall Street extremely...
Wall Street tumbled on the latest initial jobless claims numbers and fears that inflationary based rate hikes may not yet be over as everyone awaits Fed Chair Powell’s speech at...
The central banker talkfest at Jackson Hole ramps up tonight and with the slightly weaker USD plus good tech stock earnings on Wall Street, the mid week bounce on risk markets...
Bad news is good news for risk markets as the latest PMI’s for US and Europe came in softer than expected, giving some further credence that rate hikes are working and will...